Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ester Fagnano"'
Autor:
Ester Fagnano, Swati Pendharkar, Madyson Colton, Philip N. Jones, Marta Crespi Sallan, Tetyana Klymenko, Andrejs Braun, Christian Klein, Jamie Honeychurch, Eleanor J. Cheadle, Timothy M. Illidge
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
Introduction: The glycoengineered type II anti-CD20 monoclonal antibody obinutuzumab has been licensed for treatment in follicular non-Hodgkin lymphoma and B-CLL following clinical trials demonstrating superior outcomes to standard of care treatment.
Externí odkaz:
https://doaj.org/article/bf6b89e827614726966535cc78f4c00f
Autor:
Jack Gisby, Candice L Clarke, Nicholas Medjeral-Thomas, Talat H Malik, Artemis Papadaki, Paige M Mortimer, Norzawani B Buang, Shanice Lewis, Marie Pereira, Frederic Toulza, Ester Fagnano, Marie-Anne Mawhin, Emma E Dutton, Lunnathaya Tapeng, Arianne C Richard, Paul DW Kirk, Jacques Behmoaras, Eleanor Sandhu, Stephen P McAdoo, Maria F Prendecki, Matthew C Pickering, Marina Botto, Michelle Willicombe, David C Thomas, James E Peters
Publikováno v:
eLife, Vol 10 (2021)
End-stage kidney disease (ESKD) patients are at high risk of severe COVID-19. We measured 436 circulating proteins in serial blood samples from hospitalised and non-hospitalised ESKD patients with COVID-19 (n = 256 samples from 55 patients). Comparis
Externí odkaz:
https://doaj.org/article/bbf513cf4b974a538355b6474ff58476
Autor:
Maria Prendecki, Lunnathaya Tapeng, Michelle Willicombe, Marie-Anne Mawhin, Emma E Dutton, Arianne C. Richard, Candice Clarke, Talat H. Malik, Norzawani Buang, Frederic Toulza, Shanice Lewis, Paul D. W. Kirk, James E. Peters, David C. Thomas, Marie Pereira, Marina Botto, Jacques Behmoaras, Stephen P. McAdoo, Eleanor Sandhu, Matthew C. Pickering, Jack Gisby, Nicholas R. Medjeral-Thomas, Artemis Papadaki, Paige M Mortimer, Ester Fagnano
Publikováno v:
eLife
eLife, Vol 10 (2021)
eLife, Vol 10 (2021)
End-stage kidney disease (ESKD) patients are at high risk of severe COVID-19. We measured 436 circulating proteins in serial blood samples from hospitalised and non-hospitalised ESKD patients with COVID-19 (n = 256 samples from 55 patients). Comparis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5b1b888589df3719fa52070083a230f
http://hdl.handle.net/10044/1/86569
http://hdl.handle.net/10044/1/86569
Autor:
Jack Gisby, Candice L Clarke, Nicholas Medjeral-Thomas, Talat H Malik, Artemis Papadaki, Paige M Mortimer, Norzawani B Buang, Shanice Lewis, Marie Pereira, Frederic Toulza, Ester Fagnano, Marie-Anne Mawhin, Emma E Dutton, Lunnathaya Tapeng, Arianne C Richard, Paul DW Kirk, Jacques Behmoaras, Eleanor Sandhu, Stephen P McAdoo, Maria F Prendecki, Matthew C Pickering, Marina Botto, Michelle Willicombe, David C Thomas, James E Peters
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e81b4b3f9c45ecfa8c66cb5bf05142f
https://doi.org/10.7554/elife.64827.sa2
https://doi.org/10.7554/elife.64827.sa2
Autor:
Ester Fagnano, Jack Gisby, Nicholas R. Medjeral-Thomas, Paige M Mortimer, David C. Thomas, Emma E Dutton, Lunnathaya Tapeng, Paul D. W. Kirk, Marie-Anne Mawhin, Matthew C. Pickering, Artemis Papadaki, James E. Peters, Candice Clarke, Marina Botto, Jacques Behmoaras, Arianne C. Richard, Eleanor Sandhu, Stephen P. McAdoo, Talat H. Malik, Marie Pereira, Frederic Toulza, Michelle Willicombe, Shanice Lewis, Maria Prendecki, Norzawani Buang
End-stage kidney disease (ESKD) patients are at high risk of severe COVID-19. We performed dense serial blood sampling in hospitalised and non-hospitalised ESKD patients with COVID-19 (n=256 samples from 55 patients) and used Olink immunoassays to me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe76ebd1a43ff57ef6840f2aa21a1c0a
https://doi.org/10.1101/2020.11.05.20223289
https://doi.org/10.1101/2020.11.05.20223289
Publikováno v:
Leukemia & Lymphoma. 57:1269-1280
Nearly two decades ago rituximab heralded a new era in management of B cell malignancies significantly increasing response rates and survival. However, despite clear therapeutic advantage, significant numbers of patients become refractory to anti-CD2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3802b71263598708bc711314164070af
https://doi.org/10.3109/10428194.2016.1157874
https://doi.org/10.3109/10428194.2016.1157874
Autor:
Jim M. Wild, N. Farrow, Claire E. Lewis, Melanie Paul, Fiona Wright, Russell Hughes, Joe Conner, Munitta Muthana, Craig Murdoch, Jon Dobson, Aneurin J. Kennerley, Mark F. Lythgoe, Ester Fagnano, Christopher Payne, Jay Richardson
Publikováno v:
Nature Communications
Cell-based therapy exploits modified human cells to treat diseases but its targeted application in specific tissues, particularly those lying deep in the body where direct injection is not possible, has been problematic. Here we use a magnetic resona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6afa47adb514aacb6fe9ab7e4b53a222
http://europepmc.org/articles/PMC4568295
http://europepmc.org/articles/PMC4568295
Autor:
Jamie Honeychurch, Christian Klein, Simon J. Dovedi, Ester Fagnano, Timothy M Illidge, Eleanor J. Cheadle, Grazyna Lipowska-Bhalla
Publikováno v:
European Journal of Cancer. 61:S211
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2235aef98512014d9674d7ae00d27f08
https://doi.org/10.1016/s0959-8049(16)61746-x
https://doi.org/10.1016/s0959-8049(16)61746-x
Autor:
Lipowska-Bhalla, Grazyna1 (AUTHOR), Fagnano, Ester1 (AUTHOR), Illidge, Timothy M.1 (AUTHOR) tmi@manchester.ac.uk, Cheadle, Eleanor J.1 (AUTHOR)
Publikováno v:
Leukemia & Lymphoma. Jun2016, Vol. 57 Issue 6, p1269-1280. 12p.
Autor:
Baleia, Pedro
Publikováno v:
Cancer Microenvironment; Jun2018 Supplement, Vol. 11, p1-91, 91p